TC BIOPHARM HOLDINGS PLC-ADR(NASDAQ:TCBP) stock News

TCBP Latest News, Press Relases and Analysis

All

Press Releases

3 months ago - By: TC BioPharm

TC BioPharm Announces Complete Response in Minimal Residual Disease (MRD) Patient

6 months ago - By: Stocktwits - Mentions: RGC GCTK ABBV ATNM

Regencell, GlucoTrack, TC Biopharm, AbbVie, Actinium: 5 Health Care Stocks That Lit Up Retail Discussions Last Week

6 months ago - By: Benzinga - Mentions: AWH CPIX IBO WINT ...

12 Health Care Stocks Moving In Friday's After-Market Session

6 months ago - By: Stocktwits

TC BioPharm Stock Crashes On Nasdaq Delisting: Retail Expresses Frustration

6 months ago - By: Benzinga

Why TC Biopharm (TCBP) Stock Is Down Over 60% Today

6 months ago - By: TC BioPharm

TCBP Announces Transition from Nasdaq to OTC Markets

6 months ago - By: TC BioPharm

TCBP Announces Outsourcing Initiatives, Reducing Burn Rate and Overhead

7 months ago - By: TC BioPharm

TCBP to Implement ADS Ratio Change

8 months ago - By: TC BioPharm

TCBP Announces H5N1 Proof of Concept Studies Intention

8 months ago - By: TC BioPharm

TCBP to Present at Sequire Investor Summit 2025

7 months ago - By: TC BioPharm

TCBP Announces Non-Binding Letter of Intent to Acquire Commercial Stage Ophthalmic Pharmaceutical Company

7 months ago - By: TC BioPharm

TCBP Announces Successful Completion of Cohort A in the ACHIEVE Clinical Trial

8 months ago - By: TC BioPharm

TCBP Trading Continues Unabated on Nasdaq Stock Exchange

9 months ago - By: TC BioPharm

TCBP Issues 25% Stock Dividend

10 months ago - By: TC BioPharm

TCBP Awarded Non-Dilutive Funding, ScaleReady's G-Rex® Grant

7 months ago - By: TC BioPharm

TCBP Announces Successful Completion of Initial Cohort B Patient Dosing in the ACHIEVE Clinical Trial

9 months ago - By: TC BioPharm

TCBP Provides Update on Acquisition Strategy and Current Targets

9 months ago - By: TC BioPharm

TCBP Advances ACHIEVE Phase 2b Clinical Trial with Final Dosing of 3 Patients

a year ago - By: TC BioPharm

TCBP Responds to False Social Media Claim

9 months ago - By: TC BioPharm

TCBP Announces General Meeting of Shareholders to Approve One-Time Shareholder Dividend

9 months ago - By: Yahoo Finance

EXCLUSIVE: Penny Stock TC BioPharm Proposes Special Stock Dividend

9 months ago - By: TC BioPharm - Mentions: CDNA

TCBP Partners with CareDx to Support ACHIEVE Clinical Trial Using AlloCell for Pharmacokinetic Monitoring of Allogeneic Cell Therapy

10 months ago - By: TC BioPharm

TCBP Provides Quarterly Update on the ACHIEVE (UK) Clinical Trial

a year ago - By: TC BioPharm

TC BIOPHARM HOLDINGS PLC-ADR (TCBP) Stock News

TCBP Latest News, Press Relases and Analysis

TC BioPharm Announces Complete Response in Minimal Residual Disease (MRD) Patient

Regencell, GlucoTrack, TC Biopharm, AbbVie, Actinium: 5 Health Care Stocks That Lit Up Retail Discussions Last Week

12 Health Care Stocks Moving In Friday's After-Market Session

TC BioPharm Stock Crashes On Nasdaq Delisting: Retail Expresses Frustration

Why TC Biopharm (TCBP) Stock Is Down Over 60% Today

TCBP Announces Transition from Nasdaq to OTC Markets

TCBP Announces Outsourcing Initiatives, Reducing Burn Rate and Overhead

TCBP to Implement ADS Ratio Change

TCBP Announces H5N1 Proof of Concept Studies Intention

TCBP to Present at Sequire Investor Summit 2025

TCBP Announces Non-Binding Letter of Intent to Acquire Commercial Stage Ophthalmic Pharmaceutical Company

TCBP Announces Successful Completion of Cohort A in the ACHIEVE Clinical Trial

TCBP Trading Continues Unabated on Nasdaq Stock Exchange

TCBP Issues 25% Stock Dividend

TCBP Awarded Non-Dilutive Funding, ScaleReady's G-Rex® Grant

TCBP Announces Successful Completion of Initial Cohort B Patient Dosing in the ACHIEVE Clinical Trial

TCBP Provides Update on Acquisition Strategy and Current Targets

TCBP Advances ACHIEVE Phase 2b Clinical Trial with Final Dosing of 3 Patients

TCBP Responds to False Social Media Claim

TCBP Announces General Meeting of Shareholders to Approve One-Time Shareholder Dividend

EXCLUSIVE: Penny Stock TC BioPharm Proposes Special Stock Dividend

TCBP Partners with CareDx to Support ACHIEVE Clinical Trial Using AlloCell for Pharmacokinetic Monitoring of Allogeneic Cell Therapy

TCBP Provides Quarterly Update on the ACHIEVE (UK) Clinical Trial

TCBP Provides Shareholder Update and Highlights Recent Milestone Achievements